Rice Hall James & Associates’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.06M | Sell |
178,785
-15,013
| -8% | -$173K | 0.11% | 156 |
|
|
2025
Q1 | $2.91M | Buy |
193,798
+80,595
| +71% | +$1.21M | 0.17% | 128 |
|
|
2024
Q4 | $1.96M | Buy |
+113,203
| New | +$1.96M | 0.11% | 180 |
|
|
2019
Q2 | – | Sell |
-17,520
| Closed | -$1.21M | – | 278 |
|
|
2019
Q1 | $1.21M | Sell |
17,520
-215
| -1% | -$14.8K | 0.04% | 241 |
|
|
2018
Q4 | $1.06M | Sell |
17,735
-1,024
| -5% | -$61.1K | 0.04% | 244 |
|
|
2018
Q3 | $2.17M | Sell |
18,759
-111
| -0.6% | -$12.9K | 0.08% | 163 |
|
|
2018
Q2 | $2.38M | Sell |
18,870
-2,340
| -11% | -$295K | 0.09% | 169 |
|
|
2018
Q1 | $2.3M | Sell |
21,210
-94
| -0.4% | -$10.2K | 0.09% | 156 |
|
|
2017
Q4 | $2.33M | Sell |
21,304
-2,436
| -10% | -$267K | 0.09% | 178 |
|
|
2017
Q3 | $2.34M | Hold |
23,740
| – | – | 0.1% | 173 |
|
|
2017
Q2 | $2.4M | Buy |
23,740
+7
| +0% | +$709 | 0.1% | 160 |
|
|
2017
Q1 | $2.74M | Sell |
23,733
-456
| -2% | -$52.7K | 0.13% | 133 |
|
|
2016
Q4 | $2.9M | Sell |
24,189
-132
| -0.5% | -$15.8K | 0.15% | 122 |
|
|
2016
Q3 | $2.73M | Sell |
24,321
-327
| -1% | -$36.7K | 0.14% | 134 |
|
|
2016
Q2 | $3.05M | Sell |
24,648
-595
| -2% | -$73.7K | 0.18% | 106 |
|
|
2016
Q1 | $2.84M | Sell |
25,243
-453
| -2% | -$50.9K | 0.16% | 117 |
|
|
2015
Q4 | $2.79M | Sell |
25,696
-8,329
| -24% | -$906K | 0.16% | 122 |
|
|
2015
Q3 | $3.4M | Buy |
34,025
+1,273
| +4% | +$127K | 0.22% | 101 |
|
|
2015
Q2 | $3.74M | Sell |
32,752
-1,421
| -4% | -$162K | 0.22% | 104 |
|
|
2015
Q1 | $3.57M | Buy |
+34,173
| New | +$3.57M | 0.21% | 119 |
|